Bioavailability enhancement of rizatriptan benzoate by oral disintegrating strip: In vitro and in vivo evaluation

ISSN: 1875-5704 (Online)
ISSN: 1567-2018 (Print)

Volume 12, 6 Issues, 2015

Download PDF Flyer

Current Drug Delivery

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Istvan Toth
School of Pharmacy,University of Queensland
Brisbane, 4072

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.478

Bioavailability enhancement of rizatriptan benzoate by oral disintegrating strip: In vitro and in vivo evaluation

Current Drug Delivery, Volume 12 (E-pub ahead of print)

Author(s): S.T Bhagawati, Ankita D. Chonkar, Swapnil J Dengale, Sreenivasa Reddy M and Krishnamurthy Bhat.

Affiliation: Dept. of Pharmaceutical Quality Assurance Manipal College of Pharmaceutical Sciences, Manipal- 576104


Oral disintegrating strips containing rizatriptan benzoate, a selective 5- hydroxytryptaminereceptor agonist with anti migraine property, was developed using polyvinyl alcohol, sodium alginate and hydroxyl propyl methylcellulose as the base materials. The analytical and bioanalytical methods were developed and validated using HPLC (PDA and flouroscence detectors).The dissolution study performed on the strips reveal that all the five formulations, release the drug within eight minutes. Under ICH accelerated stability conditions, strips were stable at 40°C and 75% humidity for eight weeks. Furthermore, pharmacokinetic properties of oral strip were compared with rizatriptan benzoate marketed tablet. Oral disintegrating strip and tablet showed significantly higher bioavailability. Oral strip exhibited better pharmacokinetic parameters than rizatriptan marketed tablet. The Tmax, Cmax, AUC and t1/2 for oral strip were found to be 1.00 h, 64.13 ± 19.46 ng/ml, 352.00 ± 71.57 ng/ml/h and 3.09 ± 1.03 h respectively, whereas, tablet showed 1.5 h, 38.00 ± 13.43 ng/ml, 210.38 ± 40.37ng/ml/h and 1.66 ± 0.31 h respectively. These findings confirm that the rizatriptan benzoate oral disintegrating strip is potentially useful tool for an effective treatment of migraine with improved bioavailability, rapid onset of action and with increased patient compliance.


Bioavailability; HPLC; Oral disintegrating strips; Rizatriptan benzoate; Stability.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 12
First Page: 1
Page Count: 1
DOI: 10.2174/15672018113109990048
Orphan Drugs and Rare Diseases Conference

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science